**Core Concept**
The underlying principle being tested is the association between **Retinoblastoma**, a malignant tumor of the retina, and the development of secondary tumors. **Retinoblastoma** is known to increase the risk of other cancers due to genetic mutations, particularly in the **RB1 gene**.

**Why the Correct Answer is Right**
Although the specific correct answer is not provided, it's known that patients with **Retinoblastoma** have an increased risk of developing **Osteosarcoma** as a secondary tumor. This is due to the mutation in the **RB1 tumor suppressor gene**, which can lead to uncontrolled cell growth in various tissues, including bone.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific options, it's challenging to provide detailed incorrect explanations. However, typically, incorrect options might include other types of cancers or tumors that are not as strongly associated with **Retinoblastoma** as **Osteosarcoma**.
**Option B:** Similarly, without specifics, we can say that any option not recognizing the genetic predisposition to **Osteosarcoma** in **Retinoblastoma** patients would be incorrect.
**Option C:** and **Option D:** would also be incorrect for the same reason, lacking the direct association with **Osteosarcoma**.

**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that patients with **Retinoblastoma**, especially those with the heritable form, are at a significantly increased risk of developing **Osteosarcoma** and other secondary tumors. Regular follow-up and screening are essential for early detection and management of these secondary cancers.

**Correct Answer:** Unfortunately, without the provided answer choices, the exact correct answer cannot be filled in. Normally, it would be **Correct Answer: [Letter]. Osteosarcoma**.